Kansas City,
18
December
2019
|
15:30 PM
Europe/Amsterdam

Dr. Salimi Receives Grant to Study Vascular Growth Factor Angiopoietin 1

The Neonatal Diseases Research Program and Pediatric Critical Care fellowship has announced that Umar Salimi, MD, pediatric critical care fellow, has been awarded a $10,000 grant from the Little Giraffe Foundation for investigating the use of vascular growth factor angiopoietin 1 to treat acute and chronic lung injury in preclinical models of newborn sepsis.

Additionally, his work has been recognized by the Society of Critical Care Medicine with a Star Research award, and selection for plenary presentation at the society’s upcoming annual congress.

Dr. Salimi pursues his work in the Donald Thiebault neonatology laboratories under the primary mentorship of Venkatesh Sampath, MD, Director of the Neonatal Diseases Research program, and also critical care physicians Kato Han, MD, and Geoffrey Allen, MD, Chief, Pediatric Intensive Care.

His work has been supported by Neonatology and lab members including Heather Menden, MS; Sheng Xia, PhD; Sherry Mabry, MS; Wei Yu, PhD; Inamul Haque, PhD; Christopher Nitkin, MD; and Alain Cuna, MD.

About Us

Children’s Mercy Kansas City is an independent, non-profit, 386-bed pediatric health system, providing over half a million patient encounters each year for children from across the country. Children’s Mercy is ranked by U.S. News & World Report in nine specialties. We have received Magnet® recognition five times for excellence in nursing services. In affiliation with the University of Missouri-Kansas City, our faculty of more than 800 pediatric specialists and researchers is actively involved in clinical care, pediatric research and educating the next generation of pediatricians and pediatric subspecialists. The Children’s Mercy Research Institute (CMRI) integrates research and clinical care with nationally recognized expertise in genomic medicine, precision therapeutics, population health and health care innovation. In 2021 the CMRI moved into a nine-story, 375,000-square-foot space emphasizing a translational approach to research in which clinicians and researchers work together to accelerate the pace of discovery that enhances care.